Editorial: Women in lipids in cardiovascular disease by Irena Levitan, Catherine Martel, Catherine Martel

“…Frontiers in Cardiovascular Medicine…”
Get full text

Cardiovascular Risk Factors in the Antiphospholipid Syndrome by Felipe Freire da Silva, Roger Abramino Levy, Jozélio Freire de Carvalho

“…Therefore, the clinical and laboratory investigation of comorbidities known to increase cardiovascular risk in patients with antiphospholipid antibody syndrome is crucial for the adoption of a more complete and effective treatment. …”
Get full text

ABO Blood Groups and Cardiovascular Diseases by Hanrui Zhang, Ciarán J. Mooney, Muredach P. Reilly

“…ABO blood groups have been associated with various disease phenotypes, particularly cardiovascular diseases. Cardiovascular diseases are the most common causes of death in developed countries and their prevalence rate is rapidly growing in developing countries. …”
Get full text

Visfatin/Nampt: An Adipokine with Cardiovascular Impact by Tania Romacho, Carlos F. Sánchez-Ferrer, Concepción Peiró

“…Moreover, visfatin/Nampt circulating levels correlate with markers of systemic inflammation. In cardiovascular diseases, visfatin/Nampt was initially proposed as a clinical marker of atherosclerosis, endothelial dysfunction, and vascular damage, with a potential prognostic value. …”
Get full text

Dysregulation of Mitochondrial Homeostasis in Cardiovascular Diseases by Ricky Patil, Hui Wang, Matthew Kazaleh, Gorav Ailawadi, Morgan Salmon

Get full text

Adult ADHD Medications and Their Cardiovascular Implications by A. Sinha, O. Lewis, R. Kumar, S. L. H. Yeruva, B. H. Curry

“…Cardiovascular response attributed to ADHD medication has mainly been observed in heart rate and blood pressure elevations, while less is known about the etiology of rare cardiovascular events like acute myocardial infarction (AMI), arrhythmia, and cardiomyopathy and its long-term sequelae. …”
Get full text

Study of Gender in Sudden Cardiovascular Death by Rafael Emilio Araujo González, Luis Alberto Ochoa Montes, Rubén Herrera Masó, Mileidys González Lugo, Nidia Doris Tamayo Vicente, Daisy Ferrer Marrero

Subjects: “…enfermedades cardiovasculares…”
Get full text

The Impact of Bioactive Lipids on Cardiovascular Development by Alexander Kleger, Stefan Liebau, Qiong Lin, Götz von Wichert, Thomas Seufferlein

“…In this paper we will focus on the differential and developmental impact of lysophospholipids on cardiovascular development.…”
Get full text

Hypertension in the High-Cardiovascular-Risk Populations by Samy I. McFarlane, Girardin Jean-Louis, Ferdinand Zizi, Adam T. Whaley-Connell, Olugbenga Ogedegbe, Amgad N. Makaryus, Ilir Maraj

Get full text

Cardiovascular rehabilitation. Results in the cardiology service. by Juan José Navarro López, Roberto S. Vega Hernández., Claudio González Rodríguez., Teresa Rodríguez Rodríguez

Subjects: Get full text

PPAR Agonists and Cardiovascular Disease in Diabetes by Anna C. Calkin, Merlin C. Thomas

“…In recent clinical trials, PPAR𝛼 agonists have been shown to be effective in the primary prevention of cardiovascular events, while their cardiovascular benefit in patients with established cardiovascular disease remains equivocal. …”
Get full text

Cardiovascular manifestations in COVID-19 patients by Jyotsna Maddury, Mani Krishna, Achukatla Kumar

“…Preexisting conditions, such as cardiovascular disease (CVD), hypertension, diabetes, and obesity, increase the severity as well as mortality rate of COVID. …”
Get full text

A new perspective on cardiovascular function and dysfunction during endurance exercise: identifying the primary cause of cardiovascular risk by Amine Souissi, Ismail Dergaa, Samia Ernez Hajri, Karim Chamari, Helmi Ben Saad

Subjects: “…cardiovascular responses…”
Get full text

Diabetic Endothelium Dysfunction, Cardiovascular Complications, and Therapeutics by Yunzhou Dong, Yong Wu, Hyoung Chul Choi, Shuangxi Wang

Get full text

Clinical Usefulness of Atrioventricular Coupling in Cardiovascular Disease by Yang Lan, Li Zhenyi, Chen Ya, Chen Anni, Wang Xinqi, Jin Lin, Li Zhaojun

“…This review aims to summarize the physiological mechanisms and evaluation methods of AV-Coupling, as well as its clinical significance in various cardiovascular diseases.…”
Get full text

Disparities in Cardiovascular Prosthetic Device-Related Deaths by Hoang Nhat Pham, MD, Ramzi Ibrahim, MD, Mahmoud Abdelnabi, MBBCh, MSc, Mohammed Salih, MD, Mohammed Y. Khanji, MBBCh, PhD, C. Anwar A. Chahal, MBChB, PhD, Mamas A. Mamas, BMBCh, MA, DPhil, Justin Lee, MD, Kwan Lee, MD

Subjects: “…cardiovascular prosthetic device…”
Get full text

Cardiovascular Effects Mediated by HMMR and CD44 by Kinga Jaskuła, Mariusz Sacharczuk, Zbigniew Gaciong, Dominik S. Skiba

“…Cardiovascular disease (CVD) is the leading cause of death worldwide. …”
Get full text

Predictive Value of Cardiovascular Global Risk Calculation by Cynthia Morales Pérez, Milagros Lisset León Regal, Rosmari Álvarez Hernández, Yudith Brito Pérez de Corcho, José Omar de Armas García, Alejandro Muñoz Morales

Subjects: “…enfermedades cardiovasculares…”
Get full text

PPARγ and Its Role in Cardiovascular Diseases by Mini Chandra, Sumitra Miriyala, Manikandan Panchatcharam

“…The cardioprotective effect of PPARγ activation has been studied extensively over the years making them potential therapeutic targets in diseases associated with cardiovascular disorders. However, they are also associated with adverse cardiovascular events such as congestive heart failure and myocardial infarction. …”
Get full text